Trade Summary

5 days ago, Fairmount Funds Management LLC, serving as Dir at CRESCENT BIOPHARMA, INC. (CBIO), purchased 853,450 shares at $14.50 per share, for a total transaction value of $12,375,025.00. Following this transaction, Fairmount Funds Management LLC now holds 3,601,316 shares of CBIO.

This purchase represents a 31.06% increase in Fairmount Funds Management LLC's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, July 16, 2026 and publicly disclosed via SEC Form 4 filing on Monday, July 20, 2026 at 5:30 PM ET, 4 days after the trade was made.

CRESCENT BIOPHARMA, INC. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.